Innovative Bayesian statistics for enhanced decision making for pharmaceutical drug development

点击翻译按钮获取中文摘要

This project addresses Australia's national research priority of Promoting and Maintaining Good Health, and will lead to improvements in health outcomes by patients accessing new drugs sooner, enhancing research, and reducing the cost of health care. Decision making in early stages of drug development will be improved by using novel statistical methods, which could also be applied in a variety of situations involving decision making procedures. This will be achieved through cross-disciplinary and university-industry collaboration, utilising Australian and international expertise. National demands for quality science and trained researchers underpinning health decisions will be contributed to.